Cargando…
Transcranial magnetic stimulation and intravenous ketamine combination therapy for treatment-resistant bipolar depression: A case report
About a third of patients suffering from major depression develop treatment-resistant depression (TRD). Although repetitive transcranial magnetic stimulation (rTMS) and intravenous ketamine have proven effective for the management of TRD, many patients remain refractory to treatment. We present the...
Autores principales: | Elkrief, Laurent, Payette, Olivier, Foucault, Jean-Nicolas, Longpré-Poirier, Christophe, Richard, Maxime, Desbeaumes Jodoin, Véronique, Lespérance, Paul, Miron, Jean-Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532540/ https://www.ncbi.nlm.nih.gov/pubmed/36213934 http://dx.doi.org/10.3389/fpsyt.2022.986378 |
Ejemplares similares
-
“Remote Monitoring of Intranasal Ketamine Self-Administration as Maintenance Therapy in Treatment-Resistant Depression (TRD): A Novel Strategy for Vulnerable and At-Risk Populations to COVID-19?”
por: Longpré-Poirier, Christophe, et al.
Publicado: (2020) -
Allostatic load as a predictor of response to repetitive transcranial magnetic stimulation in treatment resistant depression: Research protocol and hypotheses
por: Longpré-Poirier, Christophe, et al.
Publicado: (2022) -
Repetitive transcranial magnetic stimulation for major depressive
disorder: basic principles and future directions
por: Miron, Jean-Philippe, et al.
Publicado: (2021) -
Ketamine for Bipolar Depression: Biochemical, Psychotherapeutic, and Psychedelic Approaches
por: Bennett, Raquel, et al.
Publicado: (2022) -
A Retrospective Naturalistic Study Comparing the Efficacy of Ketamine and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression
por: Mikellides, Georgios, et al.
Publicado: (2022)